Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Goodrich Petroleum Corporation (NYSE:GDP), Mack Cali Realty Corp (NYSE:CLI), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Horizon Pharma Inc (NASDAQ:HZNP)
Goodrich Petroleum Corporation (NYSE:GDP) was a volume gainer of 2.24 million shares and the average volume of the stock remained 1.99 million shares. The stock opened the session at $16.81 and finished at the end of the day at $17.26 and the stock escalated 4.04%.The market capitalization of the stock remained 753.79 million. Goodrich Petroleum Corporation is an independent oil and natural gas company engaged in exploration, development and production of oil and natural gas on properties primarily in Northwest Louisiana, East Texas and South Texas.
For How Long GDP will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Mack Cali Realty Corp (NYSE:CLI) exchanged 2.14 million shares and the average volume remained 962,359.00 shares. The stock closed the session at $20.97 with the drop of -3.59%. Mack-Cali Realty Corporation is a self-administered and self-managed real estate investment trust (REIT), which owns and operates a real estate portfolios consisted of Class A office and office/flex properties located in the Northeast.
Why Should Investors Buy CLI After the Recent Fall? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) decreased -3.35% and its closing price was $3.17. The volume of the stock was 2.14 million shares and the average volume remained 3.07 million shares. The market capitalization of the stock remained 482.19 million. The beta of the stock remained 1.36. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
Horizon Pharma Inc (NASDAQ:HZNP) exchanged 2.11 million shares in the previous trading session, and its average trading remained 1.66 million shares. HZNP advanced 2.81% and it closed the trading at $8.79. The market capitalization of the stock remained 578.89 million. Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
For How Long HZNP’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)